The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants



Status:Recruiting
Conditions:Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:1/12/2019
Start Date:October 30, 2017
End Date:June 30, 2020
Contact:Zubaida Dabre, RN BA
Email:zubaida.dabre@yale.edu
Phone:203-737-5403

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The Safety of Thoracentesis, Tunneled Pleural Catheter (Pleurx), and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants (NOAC).

To assess risks of bleeding in those individuals receiving Novel Oral Anti-Coagulant (NOAC)
medications, admitted to the hospital and require thoracentesis, chest tube or tunneled
pleural catheter placement.

The research component of this study simply observes and documents the outcomes of these
procedures. Patients will undergo an analysis of their pre-procedural hematocrit and this
will be compared to their post-procedural (next day) hematocrit.

Inclusion Criteria:

1. Age > 18 y/o

2. Unilateral or bilateral pleural effusion

3. Ability to provide consent or consent given for the procedure and research study

Exclusion Criteria:

Adults who refuse to provide consent.
We found this trial at
1
site
Yale-New Haven Hospital
20 York St, N20 York St,
New Haven, Connecticut 06520
(203) 688-4242
Phone: 203-737-5688
Yale-New Haven Hospital Relying on the skill and expertise of more than 4,500 university and...
?
mi
from
New Haven, CT
Click here to add this to my saved trials